We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 23.41%
This Fund
S&P 500
This Quarter Est. Return
+7.47%
1 Year Est. Return
+23.41%
3 Year Est. Return
+73.69%
5 Year Est. Return
+99.36%
10 Year Est. Return
+158.5%
AUM
$15.3B
AUM Growth
+$2.76B
Cap. Flow
+$1.92B
Cap. Flow %
12.55%
Top 10 Hldgs %
45.98%
Holding
1,005
New
144
Increased
321
Reduced
458
Closed
80

Sector Composition

Rank Sector Weight
1 Energy 65.79%
2 Miscellaneous 7.94%
3 Financials 6.57%
4 Healthcare 3.76%
5 Materials 2.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSRM icon
126
SSR Mining
SSRM
$7.58B
$8.28M 0.05%
838,794
+157,266
+23% +$1.6M
RGLD icon
127
Royal Gold
RGLD
$22.2B
$8.23M 0.05%
88,696
-5,794
-6% -$519K
PVG
128
DELISTED
PRETIUM RESOURCES INC.
PVG
$7.99M 0.05%
1,088,683
-36,284
-3% -$259K
B
129
Barrick Mining
B
$73.7B
$7.83M 0.05%
596,422
+4,698
+0.8% +$61.6K
AMZN icon
130
Amazon
AMZN
$2.79T
$7.63M 0.05%
+89,800
New +$7.13M
D icon
131
Dominion Energy
D
$57.9B
$7.61M 0.05%
111,558
+28,005
+34% +$1.82M
KYNB
132
Kyntra Bio
KYNB
$34.6M
$7.55M 0.05%
4,827
+427
+10% +$557K
LOXO
133
DELISTED
Loxo Oncology, Inc
LOXO
$7.54M 0.05%
43,438
+3,399
+8% +$511K
SBSW icon
134
Sibanye-Stillwater
SBSW
$9.05B
$7.49M 0.05%
3,094,552
+2,264,955
+273% +$6.98M
AGI icon
135
Alamos Gold
AGI
$15.5B
$7.36M 0.05%
1,293,780
-634,334
-33% -$3.48M
AG icon
136
First Majestic Silver
AG
$10.3B
$7.34M 0.05%
961,782
-12,011
-1% -$84.1K
FSM icon
137
Fortuna Silver Mines
FSM
$3.64B
$7.14M 0.05%
1,256,592
-85,563
-6% -$479K
UTHR icon
138
United Therapeutics
UTHR
$20.9B
$7.12M 0.05%
+62,888
New +$6.91M
AGIO icon
139
Agios Pharmaceuticals
AGIO
$1.98B
$7.02M 0.05%
83,297
+8,580
+11% +$748K
BVN icon
140
Compañía de Minas Buenaventura
BVN
$8.61B
$6.93M 0.05%
508,825
-10,344
-2% -$161K
GLIBA
141
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
$6.82M 0.04%
151,200
+3,500
+2% +$161K
EMB icon
142
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.6B
$6.79M 0.04%
63,588
+1,760
+3% +$192K
LKFT
143
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.87B
$6.76M 0.04%
73,389
+5,234
+8% +$508K
DHR icon
144
Danaher
DHR
$146B
$6.76M 0.04%
77,310
+9,560
+14% +$852K
TARO
145
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$6.7M 0.04%
57,924
+4,138
+8% +$455K
KMI icon
146
Kinder Morgan
KMI
$69.9B
$6.68M 0.04%
378,311
-8,354
-2% -$137K
MIC
147
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$6.51M 0.04%
154,336
+13,568
+10% +$533K
ARCC icon
148
Ares Capital
ARCC
$14.4B
$6.43M 0.04%
390,675
+14,200
+4% +$233K
LGND icon
149
Ligand Pharmaceuticals
LGND
$5.69B
$6.38M 0.04%
49,347
+3,974
+9% +$443K
CNP icon
150
CenterPoint Energy
CNP
$26.1B
$6.34M 0.04%
228,786
+18,031
+9% +$473K

Similar funds

ALPS Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, ALPS Advisors held 1,005 positions worth $15.3B, up 22% from $12.6B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

ALPS Advisors deployed $1.92B of net new capital in Q2 2018, opening 144 new positions and adding to 321 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 1,144 shares worth $323M.

By sector, the portfolio is most concentrated in Energy at 66% of assets, down from 67% a quarter earlier, followed by Miscellaneous and Financials.

On the sell side, the largest reduction was Dominion Energy Midstream Ptr LP, an estimated $55.1M trimmed.

  • ALPS Advisors's largest Q2 2018 buy was Berkshire Hathaway Class A: 1,144 shares worth $323M.
  • ALPS Advisors added most to JPMorgan Chase in Q2 2018, an estimated $113M increase.
  • ALPS Advisors's biggest Q2 2018 reduction was Dominion Energy Midstream Ptr LP, cutting an estimated $55.1M.
  • ALPS Advisors fully exited BeOne Medicines Ltd in Q2 2018, selling an estimated $9.35M.
  • ALPS Advisors's ten largest holdings make up 46% of its $15.3B portfolio in Q2 2018.
  • ALPS Advisors opened 144 new positions and closed 80 in Q2 2018.
  • ALPS Advisors's portfolio value rose 22% quarter-over-quarter to $15.3B.

Based on ALPS Advisors's 13F filing for Q2 2018, filed 25 Jul 2018.